BONUSCAP-ZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000HD3HL58

Market Closed - BOERSE MUENCHEN 15:46:39 2024-05-24 EDT
57.92 EUR +2.46% Intraday chart for BONUSCAP-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+11.15%
1 month+15.59%
Date Price Change
24-05-24 57.92 +2.46%
24-05-23 56.53 -1.03%
24-05-22 57.12 -1.36%
24-05-21 57.91 -1.18%
24-05-20 58.6 -0.20%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 03:46 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD3HL5
ISINDE000HD3HL58
Date issued 2024-03-08
Strike 60
Maturity 2024-06-21 (28 Days)
Parity 1 : 1
Emission price 45.23
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 59.28
Lowest since issue 34.86
Spread 0.03
Spread %0.05%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus